These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7299131)

  • 1. Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats.
    Pierce NF; Cray WC
    J Immunol; 1981 Dec; 127(6):2461-4. PubMed ID: 7299131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.
    Pierce NF; Cray WC
    J Immunol; 1982 Mar; 128(3):1311-5. PubMed ID: 6173431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.
    Pierce NF; Koster FT
    J Immunol; 1980 Jan; 124(1):307-11. PubMed ID: 6965294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M; Lycke N
    Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival immunity: compared effects of ocular or intestinal immunization in rats.
    Pu Z; Pierce NF; Silverstein AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1411-2. PubMed ID: 6618801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.
    Pierce NF
    Infect Immun; 1984 Jan; 43(1):341-6. PubMed ID: 6606625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues.
    Qimron U; Paul L; Bar-Haim E; Bloushtain N; Eisenbach L; Staats HF; Porgador A
    Vaccine; 2004 Mar; 22(11-12):1390-4. PubMed ID: 15063561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immune response to cholera toxin--cellular basis of memory and adjuvant action.
    Lycke N; Holmgren J
    Monogr Allergy; 1988; 24():274-81. PubMed ID: 3258956
    [No Abstract]   [Full Text] [Related]  

  • 12. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
    Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
    Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of mucosal immunity in humans: relevance to vaccine development.
    Czerkinsky C; Holmgren J
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():37-44. PubMed ID: 7950860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properities of lymphocytes which carry immunologic memory of phiX 174.
    McGregor DD; Mackaness GB
    J Immunol; 1975 Jan; 114(1 Pt 2):336-42. PubMed ID: 1117131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein deprivation on immunoregulatory cells in the rat mucosal immune response.
    Koster F; Pierce NF
    Clin Exp Immunol; 1985 Apr; 60(1):217-24. PubMed ID: 4006300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosa of the male genital tract; part of the common mucosal secretory immune system?
    Fritz FJ; Westermann J; Pabst R
    Eur J Immunol; 1989 Mar; 19(3):475-9. PubMed ID: 2785042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matter of timing: unsynchronized antigen expression and antigen presentation diminish secondary T cell responses.
    Elnekave M; Bivas-Benita M; Gillard GO; Sircar P; Hovav AH
    J Immunol; 2009 Jul; 183(2):1013-21. PubMed ID: 19561108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.